Form D · Biotechnology

BIOCONNECT SYSTEMS INC

Ambler, PA · CIK 0001363271

Offering snapshot reported Sep 25, 2013 · SEC filing

Reported sold
$9.07M
Offering amount: $12.5M
Investors reported
7
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Sep 18, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 25, 2013Initial$9,069,922No comparison7SEC filing
Dec 5, 2012Initial$1,485,794No comparison6SEC filing
Jan 13, 2012Initial$469,196No comparison6SEC filing
Apr 5, 2007PaperNot reportedNo comparisonNot reportedSEC filing
May 31, 2006PaperNot reportedNo comparisonNot reported
May 8, 2006PaperNot reportedNo comparisonNot reported
May 8, 2006PaperNot reportedNo comparisonNot reported

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-203529
Amount sold reflects the conversion of certain promissory notes in exchange for an equity issuance, in addition to cash proceeds.

Source: Form D, filed Sep 25, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Adam D. Dakin Director, Executive
Michael Dugery Director, Executive
Charles G. Hadley Director
Robert Weisskoff Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
124 South Maple Street, Suite 220
Ambler, PA, 19002